Organigram reports record Q4 and FY 2025 results with $123.3 million in gross revenue (+76% YoY growth).
Organigram Global Inc (NASDAQ: OGI) (TSX: OGI), Canada's top recreational cannabis company by market share, reported record results for the fourth quarter and twelve months ending on September 30, 2025. The fourth quarter of 2025 saw gross revenue of $123.3 million, marking a 76% increase year-over-year. All financial figures in this release are in Canadian dollars.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments